Gene · 8324
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
| TimeTalk uses single-cell RNA-seq datasets to decipher cell-cell communication during early embryo development. | Commun Biol | 2023 | 37660148 | PubTator, text mining | PubMed |
| Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression. | EXCLI J | 2023 | 37636026 | PubTator, text mining | PubMed |
| Use of poxvirus display to select antibodies specific for complex membrane antigens. | MAbs | 2023 | 37635331 | PubTator, text mining | PubMed |
| Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance. | Front Pharmacol | 2023 | 37601042 | PubTator, text mining | PubMed |
| A fibroblast-dependent TGFβ1/sFRP2 noncanonical Wnt signaling axis underlies epithelial metaplasia in idiopathic pulmonary fibrosis. | bioRxiv | 2023 | 37577522 | PubTator, text mining | PubMed |
| Cancer stem cells in brain tumors: From origin to clinical implications. | MedComm (2020) | 2023 | 37576862 | PubTator, text mining | PubMed |
| Characterization of the TRPV6 calcium channel-specific phenotype by RNA-seq in castration-resistant human prostate cancer cells. | Front Genet | 2023 | 37576552 | PubTator, text mining | PubMed |
| Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses. | BMC Oral Health | 2023 | 37573343 | PubTator, text mining | PubMed |
| The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases. | Front Endocrinol (Lausanne) | 2023 | 37564979 | PubTator, text mining | PubMed |
| Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma. | Cell Death Dis | 2023 | 37563118 | PubTator, text mining | PubMed |
| The specific DNA methylation landscape in focal cortical dysplasia ILAE type 3D. | Acta Neuropathol Commun | 2023 | 37559109 | PubTator, text mining | PubMed |
| Cadherin-11 increases tumor cell proliferation and metastatic potential via Wnt pathway activation. | Mol Oncol | 2023 | 37558205 | PubTator, text mining | PubMed |
| Nucleus-localized circSLC39A5 suppresses hepatocellular carcinoma development by binding to STAT1 to regulate TDG transcription. | Cancer Sci | 2023 | 37549641 | PubTator, text mining | PubMed |
| Ramifications of POU4F3 variants associated with autosomal dominant hearing loss in various molecular aspects. | Sci Rep | 2023 | 37537203 | PubTator, text mining | PubMed |
| Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations. | Nat Commun | 2023 | 37516754 | PubTator, text mining | PubMed |
| Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. | Microorganisms | 2023 | 37512809 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling Activation Induces Differentiation in Human Limbal Epithelial Stem Cells Cultured Ex Vivo. | Biomedicines | 2023 | 37509479 | PubTator, text mining | PubMed |
| Gold Nanobipyramids for Near-Infrared Fluorescence-Enhanced Imaging and Treatment of Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | 37509354 | PubTator, text mining | PubMed |
| Escin Activates Canonical Wnt/β-Catenin Signaling Pathway by Facilitating the Proteasomal Degradation of Glycogen Synthase Kinase-3β in Cultured Human Dermal Papilla Cells. | Curr Issues Mol Biol | 2023 | 37504289 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8324/papers?page=9